
Weiping Zhu
Examiner (ID: 5897, Phone: (571)272-6725 , Office: P/1733 )
| Most Active Art Unit | 1733 |
| Art Unit(s) | 1742, 1793, 1734, 1733 |
| Total Applications | 1183 |
| Issued Applications | 606 |
| Pending Applications | 6 |
| Abandoned Applications | 574 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16253885
[patent_doc_number] => 20200263259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => CTNNB1 MUTATION DETECTION KIT, METHOD, AND USE IN HCC DETECTION AND MANAGEMENT
[patent_app_type] => utility
[patent_app_number] => 16/826390
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826390 | CTNNB1 MUTATION DETECTION KIT, METHOD, AND USE IN HCC DETECTION AND MANAGEMENT | Mar 22, 2020 | Abandoned |
Array
(
[id] => 18399506
[patent_doc_number] => 11661633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Methods for predicting prostate cancer and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/819070
[patent_app_country] => US
[patent_app_date] => 2020-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 16543
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 418
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819070 | Methods for predicting prostate cancer and uses thereof | Mar 13, 2020 | Issued |
Array
(
[id] => 16484349
[patent_doc_number] => 20200377950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH STROKE, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/814085
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814085 | Genetic polymorphisms associated with stroke, methods of detection and uses thereof | Mar 9, 2020 | Issued |
Array
(
[id] => 17611901
[patent_doc_number] => 20220154180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => PRODUCTION AND AMPLIFICATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/437777
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437777 | PRODUCTION AND AMPLIFICATION OF NUCLEIC ACIDS | Mar 9, 2020 | Pending |
Array
(
[id] => 17436183
[patent_doc_number] => 11261499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Methods and nucleic acids for determining the prognosis of a cancer subject
[patent_app_type] => utility
[patent_app_number] => 16/814321
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28754
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814321
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814321 | Methods and nucleic acids for determining the prognosis of a cancer subject | Mar 9, 2020 | Issued |
Array
(
[id] => 16343986
[patent_doc_number] => 20200308636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => Method for detecting polynucleotide using FRET-PAINT
[patent_app_type] => utility
[patent_app_number] => 16/807527
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807527
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807527 | Method for detecting polynucleotide using FRET-PAINT | Mar 2, 2020 | Abandoned |
Array
(
[id] => 17015462
[patent_doc_number] => 11085089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Systems, compositions, and methods for target entity detection
[patent_app_type] => utility
[patent_app_number] => 16/805637
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 39
[patent_no_of_words] => 65544
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805637
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805637 | Systems, compositions, and methods for target entity detection | Feb 27, 2020 | Issued |
Array
(
[id] => 16206952
[patent_doc_number] => 20200239942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHOD OF MEASURING CHIMERISM
[patent_app_type] => utility
[patent_app_number] => 16/790510
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790510 | METHOD OF MEASURING CHIMERISM | Feb 12, 2020 | Abandoned |
Array
(
[id] => 16223147
[patent_doc_number] => 20200248263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => OLIGONUCLEOTIDE-COMPRISING CELLULAR COMPONENT-BINDING REAGENTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/748691
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748691 | Oligonucleotide-comprising cellular component-binding reagents and methods of using the same | Jan 20, 2020 | Issued |
Array
(
[id] => 18701646
[patent_doc_number] => 11788147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Markers of triple-negative breast cancer and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/746721
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 85
[patent_no_of_words] => 26303
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 443
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746721 | Markers of triple-negative breast cancer and uses thereof | Jan 16, 2020 | Issued |
Array
(
[id] => 19754789
[patent_doc_number] => 20250043354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => SCREENING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/310116
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310116 | SCREENING METHOD | Jan 14, 2020 | Abandoned |
Array
(
[id] => 17595772
[patent_doc_number] => 20220145346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/422967
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -201
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422967 | COMPOSITIONS AND METHODS FOR TEMPLATE-FREE GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS | Jan 12, 2020 | Issued |
Array
(
[id] => 16177311
[patent_doc_number] => 20200224279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => CO-ASSAYS TO FUNCTIONAL CANCER BIOMARKER ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/739820
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739820 | CO-ASSAYS TO FUNCTIONAL CANCER BIOMARKER ASSAYS | Jan 9, 2020 | Abandoned |
Array
(
[id] => 17299991
[patent_doc_number] => 20210395830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => USES OF METHYLATED LOCI IN SONIC HEDGEHOG MEDULLOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 17/289803
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289803 | USES OF METHYLATED LOCI IN SONIC HEDGEHOG MEDULLOBLASTOMA | Dec 26, 2019 | Abandoned |
Array
(
[id] => 18261510
[patent_doc_number] => 11609208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Devices and methods for molecule detection based on thermal stabilities of magnetic nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/727064
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 34
[patent_no_of_words] => 26463
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 431
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16727064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/727064 | Devices and methods for molecule detection based on thermal stabilities of magnetic nanoparticles | Dec 25, 2019 | Issued |
Array
(
[id] => 17611981
[patent_doc_number] => 20220154260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => OLIGONUCLEOTIDE DEPOSITION ONTO POLYPROPYLENE SUBSTRATES
[patent_app_type] => utility
[patent_app_number] => 17/421108
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421108 | OLIGONUCLEOTIDE DEPOSITION ONTO POLYPROPYLENE SUBSTRATES | Dec 18, 2019 | Pending |
Array
(
[id] => 17386054
[patent_doc_number] => 20220033906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => MIRNAS AS BIOMARKERS FOR PARKINSON'S SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/413173
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413173 | MIRNAS AS BIOMARKERS FOR PARKINSON'S SYNDROME | Dec 17, 2019 | Abandoned |
Array
(
[id] => 16269191
[patent_doc_number] => 20200270678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => PERSONALIZED THERAPEUTIC APPROACHES TO PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/592867
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16592867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/592867 | PERSONALIZED THERAPEUTIC APPROACHES TO PROSTATE CANCER | Dec 17, 2019 | Abandoned |
Array
(
[id] => 17357166
[patent_doc_number] => 20220017962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF DIAGNOSING A DISEASE STATE
[patent_app_type] => utility
[patent_app_number] => 17/299615
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299615 | METHODS OF DIAGNOSING A DISEASE STATE | Dec 3, 2019 | Pending |
Array
(
[id] => 19977442
[patent_doc_number] => 12344905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Compositions and methods for detection of
[patent_app_type] => utility
[patent_app_number] => 17/311442
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5817
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311442 | Compositions and methods for detection of | Dec 2, 2019 | Issued |